RLI COO awarded options on 8,125 shares

RLI Corp reported that Chief Operating Officer Jennifer L. Klobnak received a stock option grant on 02/02/2026.

Rhea-AI Filing Summary

RLI Corp reported that Chief Operating Officer Jennifer L. Klobnak received a stock option grant on 02/02/2026. The option covers 8,125 shares of common stock at an exercise price of $58.74 per share and is held as direct ownership.

The option becomes exercisable in stages. Starting one year from the grant date, 20% of the total shares may be exercised, with an additional 20% vesting each year thereafter in equal increments. The option is listed as exercisable beginning 02/02/2027 and expires on 02/02/2034.

Insider Trade Summary

Grant/Award: 8,125 shares

Grant/Award 1 txn

Insider Klobnak Jennifer L

Role CHIEF OPERATING OFFICER

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	8,125	$0.00	$0.00

Holdings After Transaction: Stock Option — 8,125 contracts (Direct)

Footnotes (1)

1. F1. Pursuant to option schedule wherein 20% of the aggregate number of shares granted may be exercised commencing one year from grant date and each year thereafter in 20% increments.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did RLI (RLI) disclose about Jennifer Klobnak’s recent equity award?

RLI disclosed that Chief Operating Officer Jennifer L. Klobnak received a stock option covering 8,125 shares of common stock at an exercise price of $58.74. The grant was made on February 2, 2026 and is held as directly owned.

How many RLI (RLI) shares are covered by Jennifer Klobnak’s new stock option?

The new stock option granted to Jennifer L. Klobnak covers 8,125 shares of RLI common stock. These shares are underlying a single option award that vests over time, giving her the right to buy them at a fixed exercise price if conditions are met.

What is the exercise price and term of Jennifer Klobnak’s RLI stock option?

The stock option for Jennifer L. Klobnak has an exercise price of $58.74 per share and expires on February 2, 2034. It becomes exercisable beginning February 2, 2027, giving her several years to decide when to exercise the award.

How does the vesting schedule work for RLI COO Jennifer Klobnak’s option grant?

The vesting schedule provides that 20% of the total 8,125 option shares may be exercised starting one year after the February 2, 2026 grant. Each year thereafter, another 20% becomes exercisable, resulting in full vesting in equal annual increments.

Is Jennifer Klobnak’s RLI stock option reported as directly or indirectly owned?

The filing reports Jennifer L. Klobnak’s 8,125-share stock option as directly owned. There is no indication of an intermediary entity or trust holding the award, and no footnote disclaiming her beneficial ownership or control over the option.

When did RLI grant the stock option to COO Jennifer Klobnak?

RLI granted the stock option to Chief Operating Officer Jennifer L. Klobnak on February 2, 2026. That date is listed as the transaction date for the derivative security and marks the start of the vesting schedule used for the annual 20% increments.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/03/2026 - 04:15 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Klobnak Jennifer L

(Last) (First) (Middle)

9025 N. LINDBERGH DRIVE

(Street)

PEORIA IL 61615

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
RLI CORP [ RLI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF OPERATING OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
02/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$58.74	02/02/2026		A		8,125		02/02/2027(1)	02/02/2034	Common Stock	8,125	$0	8,125	D

Explanation of Responses:

1. Pursuant to option schedule wherein 20% of the aggregate number of shares granted may be exercised commencing one year from grant date and each year thereafter in 20% increments.

	/s/ Jennifer L. Klobnak	02/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.